Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Conditions
Interventions
Intervention1: Fesoterodine: Tablet Fesoterodine 4mg once daily per oral for 6 weeks
Control Intervention1: Solifenacin: Tablet Solifenacin 5mg once daily per oral for 6 weeks
Control Intervention2: T
Sponsors
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients requiring stent insertion for short term indications such as pyeloplasty or surgery for urolithiasis
Exclusion criteria
Exclusion criteria: Lower Urinary Tract Symptoms before stent insertion Benign Prostatic Enlargement with IPSS more than 7 History of urinary tract surgery other than the current one Use of alpha-1 blockers, anticholinergics, or analgesics prior to stent insertion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary symptoms like frequency, urgency, nocturia Pain scoreTimepoint: 2 days and 2 weeks post DJ stent insertion and 2 days post DJ stent removal | — |
Secondary
| Measure | Time frame |
|---|---|
| Side eKects like constipation, dry mouth, dizziness, blurred vision, hematuriaTimepoint: 2 days and 2 weeks post DJ stent insertion and 2 days post DJ stent removal;Quality of life by USSQ questionnaireTimepoint: 2 days and 2 weeks post DJ stent insertion and 2 days post DJ stent removal;Stent-related complications like pyelonephritis, urinary fistula, UTI episodesTimepoint: 2 days and 2 weeks post DJ stent insertion and 2 days post DJ stent removal;Financial burden and days in situTimepoint: 2 days post DJ stent removal | — |
Countries
India
Contacts
Public ContactSanchit Rustagi
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Outcome results
None listed